Literature DB >> 10075010

Chromosomal clues to the development of prostate tumors.

A R Brothman1, T M Maxwell, J Cui, D A Deubler, X L Zhu.   

Abstract

BACKGROUND: Cytogenetic, molecular cytogenetic, and molecular studies of prostate cancer have revealed an enormous amount of data regarding chromosomal loci that are aberrant in prostate tumors.
METHODS: These data have been compared and condensed in this review to determine which chromosomes and chromosome sites have been most frequently reported.
RESULTS: Loss of the Y chromosome, gain of 7, 8, and X, and interstitial deletions on 6q, 7q, 8p, 10q, 13q, 16q, 17q, and 18q are the most prevalent.
CONCLUSIONS: A potential model for genetic control of tumor progression is presented, as are data regarding the evaluation of a new series of tumors.

Entities:  

Mesh:

Year:  1999        PMID: 10075010     DOI: 10.1002/(sici)1097-0045(19990301)38:4<303::aid-pros6>3.0.co;2-e

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  15 in total

1.  Identification of a high frequency of chromosomal rearrangements in the centromeric regions of prostate cancer cell lines by sequential giemsa banding and spectral karyotyping.

Authors:  B Beheshti; J Karaskova; P C Park; J A Squire; B G Beatty
Journal:  Mol Diagn       Date:  2000-03

2.  A Y chromosomal influence on prostate cancer risk: the multi-ethnic cohort study.

Authors:  S Paracchini; C L Pearce; L N Kolonel; D Altshuler; B E Henderson; C Tyler-Smith
Journal:  J Med Genet       Date:  2003-11       Impact factor: 6.318

3.  PROTEOME-3D: an interactive bioinformatics tool for large-scale data exploration and knowledge discovery.

Authors:  Deborah H Lundgren; Jimmy Eng; Michael E Wright; David K Han
Journal:  Mol Cell Proteomics       Date:  2003-09-07       Impact factor: 5.911

4.  Detection of deleted in malignant brain tumors 1 and runt-related transcription factor 3 gene expressions in bladder carcinoma.

Authors:  Yavuz Dodurga; Cığır Biray Avcı; N Lale Satiroglu-Tufan; Canten Tataroglu; Zehra Kesen; Z Ozlem Doğan; Sunde Yılmaz; Cumhur Gündüz
Journal:  Mol Biol Rep       Date:  2011-09-29       Impact factor: 2.316

5.  Frequency of the TMPRSS2:ERG gene fusion is increased in moderate to poorly differentiated prostate cancers.

Authors:  Ashish B Rajput; Melinda A Miller; Alessandro De Luca; Niki Boyd; Sam Leung; Antonio Hurtado-Coll; Ladan Fazli; Edward C Jones; Jodie B Palmer; Martin E Gleave; Michael E Cox; David G Huntsman
Journal:  J Clin Pathol       Date:  2007-01-26       Impact factor: 3.411

6.  Microchimeric Cells, Sex Chromosome Aneuploidies and Cancer.

Authors:  Deniz Taştemir Korkmaz; Osman Demirhan; Deniz Abat; Bülent Demirberk; Erdal Tunç; Sedat Kuleci
Journal:  Pathol Oncol Res       Date:  2015-05-24       Impact factor: 3.201

7.  Molecular cytogenetic analysis of prostatic adenocarcinomas from screening studies : early cancers may contain aggressive genetic features.

Authors:  J C Alers; P J Krijtenburg; A N Vis; R F Hoedemaeker; M F Wildhagen; W C Hop; T T van Der Kwast; F H Schröder; H J Tanke; H van Dekken
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

8.  Identification of specific Y chromosomes associated with increased prostate cancer risk.

Authors:  Lisa A Cannon-Albright; James M Farnham; Matthew Bailey; Frederick S Albright; Craig C Teerlink; Neeraj Agarwal; Robert A Stephenson; Alun Thomas
Journal:  Prostate       Date:  2014-05-06       Impact factor: 4.104

9.  Y chromosome haplogroups and prostate cancer in populations of European and Ashkenazi Jewish ancestry.

Authors:  Zhaoming Wang; Hemang Parikh; Jinping Jia; Timothy Myers; Meredith Yeager; Kevin B Jacobs; Amy Hutchinson; Laurie Burdett; Arpita Ghosh; Michael J Thun; Susan M Gapstur; W Ryan Diver; Jarmo Virtamo; Demetrius Albanes; Geraldine Cancel-Tassin; Antoine Valeri; Olivier Cussenot; Kenneth Offit; Ed Giovannucci; Jing Ma; Meir J Stampfer; J Michael Gaziano; David J Hunter; Ana Dutra-Clarke; Tomas Kirchhoff; Michael Alavanja; Laura B Freeman; Stella Koutros; Robert Hoover; Sonja I Berndt; Richard B Hayes; Ilir Agalliu; Robert D Burk; Sholom Wacholder; Gilles Thomas; Laufey Amundadottir
Journal:  Hum Genet       Date:  2012-01-24       Impact factor: 4.132

10.  The genomic landscape of prostate cancer.

Authors:  Sylvan C Baca; Levi A Garraway
Journal:  Front Endocrinol (Lausanne)       Date:  2012-05-16       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.